Skip to main content

Table 1 Baseline characteristics for mitral valve diseases

From: The impact of medical insurance reimbursement on postoperative inflammation reaction in distinct cardiac surgery from a single center

Characteristics Group A
(n = 235)
Group B
(n = 179)
Group C
(n = 101)
F/X2 value aP value
Age, y 54.4 ± 11.2 54.3 ± 10.1 52.7 ± 10.3 0.952 0.387
Male (n, %) 65(46.4%) 65(46.1%) 38(37.6%) 2.254 0.324
Body Mass Index, kg/m2 21.9 ± 1.9 22.0 ± 2.0 22.3 ± 2.4 1.248 0.288
Current smoking (n) 18 11 13 4.042 0.133
drinking status (n) 7 9 5 1.336 0.513
inactivity status (n) 89 71 38 0.865 0.649
 ≥ High school Education level(n) 66 65 37 4.050 0.132
LVEF, % 56.7 ± 8.5 56.7 ± 7.7 57.2 ± 6.4 0.180 0.835
LVEDD, mm 52.4 ± 6.9 52.1 ± 6.7 51.6 ± 7.1 0.525 0.592
LAD, mm 52.4 ± 6.9 52.7 ± 6.3 53.8 ± 7.6 1.311 0.270
NYHA, I
II
III
33
107
95
18
86
75
10
54
37
3.143 0.534
Mitral valvuloplasty /replacement 89/146 72/107 36/65 0.600 0.741
Euroscore 2.0 ± 1.3 1.9 ± 1.3 2.0 ± 1.2 0.169 0.845
  1. Group A: low medical coverage; Group B: medium medical coverage; Group C: high medical coverage
  2. BMI Body Mass Index, LVEF left ventricular ejection fraction, LVEDD left ventricular end-diastolic dimension, LAD left atrium dimension, NYHA New York Heart Association
  3. ap values obtained from the repeated measures ANOVA (continuous variables) and Pearson Chi-squared tests or Fischer’s exact (dichotomous variables)